Initial application of transanal endoscopic microsurgery for high-risk lower rectal gastrointestinal stromal tumor after imatinib mesylate neoadjuvant chemotherapy: A case report

RATIONALE: The lower rectal gastrointestinal stromal tumor (GIST) is a rare entity and warrants special attentions because of the considerations of preserving of anal and urinal functions. Neoadjuvant therapy with imatinib mesylate (IM) has achieved great success in GIST, which potentially extends t...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Qiaofei, Zhong, Guangxi, Zhou, Weixun, Lin, Guole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
7100
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521910/
https://www.ncbi.nlm.nih.gov/pubmed/28723770
http://dx.doi.org/10.1097/MD.0000000000007538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521910/
https://www.ncbi.nlm.nih.gov/pubmed/28723770
http://dx.doi.org/10.1097/MD.0000000000007538

Ejemplares similares